Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Summit pulls off a downsized IPO for its DMD drug
Summit pulls off a downsized IPO for its DMD drug
Summit pulls off a downsized IPO for its DMD drug
Submitted by
admin
on March 5, 2015 - 8:55am
Source:
Fierce Biotech
News Tags:
Duchenne Muscular Dystrophy
Summit Therapeutics
SMT C1100
IPOs
Headline:
Summit pulls off a downsized IPO for its DMD drug
Do Not Allow Advertisers to Use My Personal information